ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster
This multicenter RCT aims to compare the efficacy and safety of Brivudine versus Famciclovir in treating acute herpes zoster. Primary objective: Evaluate pain reduction via Numeric Pain Rating Scale (NPRS) at Day 30. Secondary objectives: Compare NPRS at Day 3/Day 7/Day 14/Day 90, time to lesion resolution, Postherpetic Neuralgia (PHN) incidence, and safety.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Reduction of Postherpetic Neuralgia in Herpes Zoster#829874
- Rhomboid Intercostal and Subserratus Plane Block Versus Paravertebral Block for Thoracic Herpes Zoster#850507
- Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation#1075372
- The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster#966191
- The Effectiveness of Wet Cupping on Persistent Non-specific Low Back Pain#846188
Record · ID 1074663
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive